share_log

Unicycive Therapeutics Reports Publication Of Preclinical Data In American Society Of Nephrology Journal, Kidney360

Benzinga ·  Feb 20 12:33

Data demonstrated sizeable reductions in urinary phosphate excretion (a proxy for intestinal phosphate absorption) in response to both OLC monotherapy and the combination of OLC with tenapanor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 416

Recommended

Write a comment